DSIP 5 mg

Subtotal	$0.00
Shipping	$0.00
Total	$0.00

DSIP 5 mg - Peptide Sciences USA Research Peptides

Active Substance: Delta-sleep-inducing peptide
Concentration: 5 mg per vial
Pack Size: Single vial (lyophilized powder)
Manufacturer: Peptide Sciences USA
Brand Name: DSIP
Molecular Formula: C₃₅H₄₈N₁₀O₁₅
Molecular Weight: 848.81 g/mol
Sequence: Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu
Synonyms: Delta-sleep-inducing peptide, WAGGDASGE

Manufacturer	Peptide Sciences USA
Brand	DSIP
Substance	Delta-sleep-inducing peptide
Concentration	5 mg
Pack Size	vial

Out of Stock

Research Peptides Description

DSIP 5 mg – Conductor of Restorative Sleep

Product Summary

Picture a research frontier where deep sleep restores the body, stress fades, and vitality thrives. DSIP 5 mg vial from Peptide Sciences USA, a neuropeptide, makes this vision a reality. By promoting slow-wave sleep, reducing stress responses, and modulating hormones, DSIP offers a prestigious tool for pioneering sleep, stress, and longevity research.

How DSIP Works

Delta-sleep-inducing peptide (DSIP), a nonapeptide with the sequence Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu, is a neuromodulator found in the hypothalamus, pituitary, and peripheral tissues. It crosses the blood-brain barrier and interacts with NMDA, delta-opioid, and GABA-A receptors to promote slow-wave sleep (SWS), reducing sleep latency and increasing sleep efficiency by up to 59% in chronic insomnia models. DSIP also modulates the hypothalamic-pituitary-adrenal (HPA) axis, decreasing corticotropin and cortisol levels while stimulating luteinizing hormone (LH) and growth hormone (GH) release.

In preclinical studies, DSIP (120 µg/kg intranasally) reduced stroke-induced brain infarction in rats and enhanced oxidative phosphorylation in mitochondria, suggesting antioxidant and neuroprotective effects. It also lowered pain perception in 6/7 patients with chronic pain and reduced opioid withdrawal symptoms in 97% of cases, indicating analgesic and anti-addictive potential. These properties make DSIP a versatile candidate for researching sleep disorders, stress management, and neuroendocrine function.

Why Choose DSIP 5 mg?

DSIP is a trailblazer in sleep and stress response research, offering multifaceted benefits. Here's why it stands out:

Sleep Regulation: Promotes slow-wave sleep, increasing sleep time by 59% and reducing latency in insomnia models, enhancing restorative sleep.
Stress Protection: Modulates HPA axis, reducing cortisol and stress-induced metabolic disorders, ideal for stress resilience studies.
Neuroprotection: Enhances mitochondrial function and reduces stroke-related brain damage, supporting brain health research.
Hormonal Modulation: Stimulates LH and GH release, inhibits somatostatin, and supports endocrine balance in preclinical models.
Premier Quality: Peptide Sciences USA ensures 99% purity through advanced synthesis, guaranteeing reliable research outcomes.

DSIP 5 mg empowers researchers to revolutionize sleep and stress research, backed by cutting-edge neuropeptide science.

Product Specifications

Peptide Sciences USA's DSIP 5 mg vial is crafted for precision in sleep and neuroendocrine research, delivering exceptional quality. Here's the breakdown:

Composition: Contains 5 mg of DSIP (C₃₅H₄₈N₁₀O₁₅, molecular weight 848.81 g/mol).
Pack Size: Single vial of lyophilized powder, requiring reconstitution for subcutaneous or intravenous injection.
Manufacturing: Produced by Peptide Sciences USA with 99% purity, verified by High-Performance Liquid Chromatography and Mass Spectrometry.
Usage Guidelines: Reconstitute with bacteriostatic water and administer via subcutaneous or intravenous injection, typically at 100–300 mcg/day, often in the evening, in research protocols under professional supervision.
Storage: Store lyophilized powder at -20°C. After reconstitution, refrigerate at 2–8°C for up to 5 days or freeze at -20°C for up to 3 months, avoiding repeated freeze-thaw cycles.
Safety: Preclinical studies report minimal side effects like mild headaches or transient arousal; limited human data requires research oversight.

This peptide is for research purposes only, providing a robust platform for studying sleep and stress regulation.

Legal Disclaimer

DSIP 5 mg is supplied for research purposes only and is not FDA-approved for human use. It is not intended to diagnose, treat, cure, or prevent any condition. Consult a licensed professional before use. Peptide Sciences USA assumes no liability for misuse. All information is educational and based on preclinical research.

Frequently Asked Questions

What is DSIP used for?

DSIP is used in research to explore sleep regulation, stress response, neuroprotection, and hormonal modulation. It promotes slow-wave sleep, reduces stress-induced metabolic disorders, and supports pain management and opioid withdrawal in preclinical models.

Does DSIP increase growth hormones?

Yes, preclinical studies show DSIP stimulates growth hormone (GH) release by inhibiting somatostatin and enhancing hypothalamic neural circuitry, increasing GH levels significantly within 30–120 minutes post-injection in animal models.

How long does it take for DSIP to work?

In research, DSIP induces feelings of sleepiness within 10–60 minutes post-injection and increases sleep time by 59% within 130 minutes. Sustained sleep improvements may take 3–7 days, with full circadian reset in 2–3 weeks in chronic insomnia models.

Does DSIP increase testosterone?

DSIP indirectly supports testosterone production by stimulating luteinizing hormone (LH) release via hypothalamic pathways, observed in animal models. However, no direct evidence confirms significant testosterone increases in humans, requiring further research.

How is DSIP 5 mg administered in research?

DSIP is supplied as a 5 mg lyophilized powder. Reconstitute with bacteriostatic water and administer via subcutaneous or intravenous injection, typically at 100–300 mcg/day, often in the evening, in research protocols under professional guidance.